← SynDRA
VK5211
SynDRA canonical compound SYN0040553 — structure-anchored drug synonym record
| Clinical phase | Phase 2 |
|---|
| Primary target(s) | AR | SARM1 |
|---|
| Mechanism of action | androgen receptor modulator |
|---|
| Indication | cachexia |
|---|
| Disease area | endocrinology |
|---|
All known targets
Mechanisms of action (all sources)
Cross-references
Synonyms
- Ligandrol
- Vk-5211
- LGD-4033
- 1EJT54415A
- LIGANDROL [NFLIS-DRUG]
- LIGANDROL (NFLIS-DRUG)
- RefChem:902038
- Ligandrol (LGD-4033)
- UNII-1EJT54415A
- LGD4033
- C14H12F6N2O
- MFCD27923016
- LIGANDROL;LGD-4033
- SCHEMBL221159
- LGD-4033 (1R-isomer)
- orb2276871
- SCHEMBL29362482
- LGD4033(LG)
- EX-A729
- OPSIVAKKLQRWKC-VXGBXAGGSA-N
- VK 5211 [WHO-DD]
- MSK10563
- BDBM50598587
- s8822
- AKOS022173564
- CS-4667
- LGD-4033(VK-5211)
- Ligandrol (VK5211, LGD-4033)?
- AC-30218
- AS-85298
- FT102147
- HY-13981
- NS00073090
- T15750
- ligandrol
- リガンドロール
Look up VK5211 in the interactive SynDRA portal →